Thromb Haemost 2025; 125(09): 821-824
DOI: 10.1055/a-2510-6370
DOI: 10.1055/a-2510-6370
Invited Clinical Focus
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban
Mehrdad Zarghami
1
Department of Medicine, Jamaica Hospital Medical Center, Queens, New York, United
States
2
Division of Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts, United States
,
Sina Rashedi
3
Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston,
Massachusetts, United States
,
Gregory Piazza
2
Division of Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts, United States
3
Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston,
Massachusetts, United States
,
Marie Denise Gerhard-Herman
2
Division of Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts, United States
,
4
Frankel Cardiovascular Center, University of Michigan Ann Arbor, Michigan, United
States
,
Behnood Bikdeli
2
Division of Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts, United States
3
Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston,
Massachusetts, United States
5
YNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut,
United States
› Institutsangaben